Nagasue N, Kohno H, Hayashi T, Yamanoi A, Uchida M, Takemoto Y, Makino Y, Ono T, Hayashi J, Nakamura T
Second Department of Surgery, Shimane Medical University, Izumo, Japan.
Gastroenterology. 1993 Nov;105(5):1449-54. doi: 10.1016/0016-5085(93)90150-b.
From biological and clinical perspectives, it is important to clarify tumor heterogeneity. This study was aimed to investigate whether or not intratumoral heterogeneity of DNA ploidy pattern exists in hepatocellular carcinoma (HCC).
Using fresh materials resected from 31 untreated patients, DNA ploidy was analyzed at different sites of the same HCC by means of flow cytometry. The tumor size ranged from 1.7 to 25.0 cm.
There was no case in which euploid and aneuploid HCCs coexisted in the same tumor. The DNA ploidy pattern was euploid in 15 and aneuploid in 16 instances. Of 15 euploid tumors, the areas analyzed were all diploid in 12 and tetraploid in 2 but diploid/tetraploid in 1. Among 16 aneuploid tumors, the DNA indices (DI) at different sites were similar in 9, but apparently, different aneuploid subclones coexisted in 7 cases. The incidence of DI heterogeneity in aneuploid HCCs was similar between small (< 5 cm) and large (> or = 5 cm) tumors; 3 of 7 (42.9%) versus 4 of 9 (44.4%).
It is assumed that euploid and aneuploid HCCs develop in their own ploidy pattern and that the evolution of aneuploid subpopulations from euploid HCC is rare, but new aneuploid subclones can evolve from aneuploid HCC due to increased instability of its karyotype.
从生物学和临床角度来看,阐明肿瘤异质性很重要。本研究旨在调查肝细胞癌(HCC)中是否存在DNA倍体模式的肿瘤内异质性。
使用从31例未经治疗的患者切除的新鲜材料,通过流式细胞术分析同一HCC不同部位的DNA倍体。肿瘤大小范围为1.7至25.0厘米。
同一肿瘤中同时存在整倍体和非整倍体HCC的情况不存在。DNA倍体模式为整倍体的有15例,非整倍体的有16例。在15例整倍体肿瘤中,分析区域全部为二倍体的有12例,四倍体的有2例,但有1例为二倍体/四倍体。在16例非整倍体肿瘤中,9例不同部位的DNA指数(DI)相似,但7例明显存在不同的非整倍体亚克隆共存。小肿瘤(<5厘米)和大肿瘤(≥5厘米)中非整倍体HCC的DI异质性发生率相似;7例中的3例(42.9%)对9例中的4例(44.4%)。
假定整倍体和非整倍体HCC以各自的倍体模式发展,并且从整倍体HCC进化出非整倍体亚群的情况很少见,但由于其核型不稳定性增加,非整倍体HCC可进化出新的非整倍体亚克隆。